Perspective Therapeutics (CATX) Non-cash Items (2011 - 2025)
Perspective Therapeutics' (CATX) quarterly Non-cash Items came in at $5.4 million in Q4 2025, down 99.86% year-on-year from $3.8 billion in Q4 2024, and down 99.86% quarter-over-quarter from $3.8 billion in Q4 2024.
Perspective Therapeutics (CATX) Non-cash Items (2011 - 2025) Analysis & Trends
Perspective Therapeutics has disclosed Non-cash Items across 15 years of filings, most recently posting $5.4 million for Q4 2025.
- Non-cash Items for Q4 2025 came in at $5.4 million, down 99.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.4 million (down 99.86% YoY), and the FY2025 annual result was $5.4 million, up 35.85% from the prior year.
- Non-cash Items came in at $5.4 million for Q4 2025 at Perspective Therapeutics, down from $3.8 billion in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $6.7 billion in Q4 2023 to a low of $2000.0 in Q2 2022.
- The 5-year median for Non-cash Items is $6.0 million (2022), against an average of $961.0 million.
- Across the five-year window, Non-cash Items jumped 685200.0% in 2023 and slumped 99.86% in 2025, its largest moves.
- Perspective Therapeutics' Non-cash Items stood at $4.2 million in 2021, then soared by 41.58% to $6.0 million in 2022, then jumped by 111956.3% to $6.7 billion in 2023, then sank by 42.76% to $3.8 billion in 2024, then plunged by 99.86% to $5.4 million in 2025.
- The last three Non-cash Items figures came in at $5.4 million (Q4 2025), $3.8 billion (Q4 2024), and $6.7 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 3.82 Bn |
| Dec 31, 2024 | 3.82 Bn |
| Dec 31, 2023 | 6.67 Bn |
| Dec 31, 2023 | 6.67 Bn |
| Sep 30, 2023 | 34.88 Mn |
| Sep 30, 2023 | 34.88 Mn |
| Jun 30, 2023 | 13.71 Mn |
| Jun 30, 2023 | 13.71 Mn |
| Mar 31, 2023 | 12.99 Mn |
| Mar 31, 2023 | 12.99 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Sep 30, 2021 | 4.21 Mn |
| Sep 30, 2021 | 4.21 Mn |
| Jun 30, 2021 | 984,000.00 |
| Jun 30, 2021 | 984,000.00 |